Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 21, 2021

SELL
$100.0 - $143.02 $177,400 - $253,717
-1,774 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$78.27 - $151.29 $138,850 - $268,388
1,774 New
1,774 $251,000
Q1 2021

Apr 29, 2021

SELL
$94.25 - $132.81 $167,199 - $235,604
-1,774 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$102.03 - $184.62 $181,001 - $327,515
1,774 New
1,774 $219,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Aaron Wealth Advisors LLC Portfolio

Follow Aaron Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aaron Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aaron Wealth Advisors LLC with notifications on news.